REBL Innovations

Welcome to REBL Innovations

We are currently developing an innovative shunt for treating hydrocephalus. Our invention, the Inflatashield, will drastically minimize the number of revisions surgeries patients must undergo, improving quality of life, and saving millions of dollars annually.

Quick overview:
Founded in
September 2010, REBL Innovations has been developing a cutting-edge ventriculoperitoneal shunt design to address the excessively high revision rate caused by device failure due to occlusion.

The team is composed of four Biomedical Engineers from Columbia University in the Biomechanics and Cell & Tissue engineering tracks with diverse research backgrounds.

On May 3, 2011, REBL Innovations will be unveiling the latest prototype of their device at the Senior Design Expo in Davis Auditorium at Columbia University.